Detalhe da pesquisa
1.
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet
; 401(10372): 195-203, 2023 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681415
2.
Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113.
Oncologist
; 29(1): e97-e107, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531645
3.
A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX).
Jpn J Clin Oncol
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38693750
4.
A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
Jpn J Clin Oncol
; 54(1): 103-107, 2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801434
5.
Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
BMC Cancer
; 23(1): 219, 2023 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890471
6.
A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006.
Future Oncol
; 19(28): 1897-1904, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37750332
7.
Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancer.
Future Oncol
; 19(23): 1593-1600, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584156
8.
Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311).
Int J Gynecol Cancer
; 33(5): 692-700, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997229
9.
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306.
Br J Cancer
; 127(8): 1487-1496, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35871234
10.
Management of elderly patients with early gastric cancer in Japan.
Jpn J Clin Oncol
; 52(5): 425-432, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301534
11.
Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer.
Jpn J Clin Oncol
; 52(4): 383-387, 2022 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999817
12.
A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610.
Jpn J Clin Oncol
; 52(9): 1021-1028, 2022 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35472141
13.
Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: a single-arm confirmatory multicenter study: Japan Clinical Oncology Group study JCOG1906 (EVERGREEN study).
Jpn J Clin Oncol
; 51(8): 1330-1333, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021345
14.
A multi-institutional randomized phase III trial comparing postoperative radiotherapy to observation after adjuvant chemotherapy in patients with pathological N2 Stage III non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1916 (J-PORT study).
Jpn J Clin Oncol
; 51(6): 999-1003, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772279
15.
A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914.
Jpn J Clin Oncol
; 51(5): 836-841, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33728436
16.
The impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practice.
Support Care Cancer
; 29(5): 2255-2258, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33392774
17.
Study protocol for a multi-institutional randomized phase III study comparing combined everolimus plus lanreotide therapy and everolimus monotherapy in patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors; Japan Clinical Oncology Group Study JCOG1901 (STARTER-NET study).
Pancreatology
; 20(6): 1183-1188, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798144
18.
A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study).
Jpn J Clin Oncol
; 50(7): 821-825, 2020 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424430
19.
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines.
Support Care Cancer
; 28(5): 2473-2484, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052137
20.
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines.
Support Care Cancer
; 27(10): 3949-3967, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31286232